mat Editus.lu
Verfollegt d'Blogger ! Fannt d'Apdikte vum Déngscht ! inspiréiert Iech ! reservéiert Ären Dësch ! tauscht Iech mat Äre Gemeinschaften aus ! huelt RDV beim Dokter ! Fannt dee gudde Kontakt ! spuert d'ganzt Joer ! Informéiert Iech iwwer de Maart ! D'Verkéiersinfo kucken! D'Wieder kucken ! tauscht Iech mat Fachleit aus ! schafft un Ärem Netz ! prospektéiert effizient ! Profitéiert vu gudde Rotschléi ! Verfollegt Fachleit ! profitéiert vun de Rotschléi vun de Blogger ! Fannt eng Aarbecht ! D'Noutruffnummere kucken ! Fannt eng Immobilie ! Fannt eng Parkplaz ! Lëtzebuerg entdecken ! Fachleit empfeelen ! Ären Horoskop kucken ! De Kinosplang entdecken ! Gitt Är Meenung !
Sech umellen séieren Zougank
W11012151FIA.GIF Shire Phamaceuticals International Finance Sàrl

1 Rue Hildegard von Bingen L-1282 Luxembourg (Lëtzebuerg)

D'Nummer uweisen +352 26 49 58 4494

Iwwer Shire Phamaceuticals International Finance Sàrl

At Shire, we are champions for people around the world who are struggling with rare diseases – they are at the center of everything we do.

Focusing on a Significant Unmet Medical Need

Rare diseases, most of which are genetic and are present throughout a person's entire life, pose a significant medical and economic burden for patients, communities and healthcare systems. There are more than 7,000 known rare diseases, including Hemophilia, Hereditary Angioedema (HAE), Gaucher disease, Hunter Syndrome, and many forms of rare cancer, and an estimated 350 million people worldwide are living with one.1

These figures do not reflect the untold number of family members and friends who watch a loved one struggle with health challenges that, in many cases, cannot be adequately addressed today, especially considering nearly half of the time these loved ones are children. What's more, patients with rare diseases commonly experience delays to diagnosis, which can lead to serious consequences for their health and the wider healthcare system.

Innovation and Collaboration Will Lead to Breakthrough Progress

This unmet need drives our unique model for innovation, which is a mix of internal knowledge, capabilities and research, combined with collaborations with external partners, patients, doctors, caregivers and advocacy groups, and supplemented by M&A and licensing.

As we look to the future, we are sharply focused on developing new medicines in our chosen therapeutic areas that deliver value and progress for all impacted. We are also committed to working alongside governments and payers to deliver meaningful outcomes that help ease the long-term burden of these diseases for patients and all who support them on their journey.

Et si keng Effnungszäite verfügbar fir Shire Phamaceuticals International Finance Sàrl
Längegrad :

6,118594

Breedegrad :

49,582246

Eis Entscheeder

M. Léonard De Waal

Gérant

D'Nummer uweisen +352 26 49 58 4494

Zousätzlech Informatiounen

Eis Produkter an Zerwisser

eis administrativ a finanziell Infoen

  • Nace : Sociétés de participation financière (Soparfi) (64202)
  • N° vum Handelsregister : B200835
  • International TVAsnummer : LU28120049
  • Kapital : 25 000 €
  • Grënnungsdatum : 10.2015
Autres professionnels pour Holding :
Aner Fachleit no bei Luxembourg :
Andeems Dir um Site internet Editus.lu navigéiert :
Ech erkennen un d'Dateschutzriichtlinn an déi Allgemeng Notzungsbedéngunge vun Editus zur Kenntnis geholl a verstan hunn. Ech erkennen un dës akzeptéiert ze hunn.

Ech akzeptéieren och d'Notze vu Cookies an ähnlech Technologie an de virgesinnene Bedéngungen an der Dateschutzriichtlinn vun Editus.lu.

Fir méi driwwer gewuer ze ginn an d'Cookien an ähnlech Technlogien anzestellen, klickt hei.